Table 2. Hemodynamic variables.
baseline | drug perfusion | ischemia | reperfusion | ||
---|---|---|---|---|---|
30 | 30 | 60 | |||
Heart Rate (bpm) | |||||
con | 334 ± 37 | 316 ± 36 | 238 ± 43* | 249 ± 41* | |
sil | 295 ± 40 | 305 ± 43 | 226 ± 117 | 244 ± 39 | |
kt+sil | 313 ± 57 | 306 ± 54 | 198 ± 109* | 252 ± 56 | |
kt | 317 ± 32 | 298 ± 36 | 287 ± 48 | 256 ± 34 | |
RPP (mmHg * bpm) | |||||
con | 38004 ± 6029 | 35803 ± 6717 | 6021 ± 3845* | 7840 ± 3220* | |
sil | 34296 ± 4887 | 35525 ± 4167 | 4036 ± 2255* | 5964 ± 2297* | |
kt+sil | 36083 ± 6829 | 32697 ± 4745 | 6403 ± 5231* | 6076 ± 2809* | |
kt | 37895 ± 6834 | 33894 ± 3521 | 6300 ± 4834* | 6736 ± 3338* | |
LVEDP (mmHg) | |||||
con | 4 ± 2 | 5 ± 4 | 32 ± 13* | 72 ± 12* | 66 ± 9* |
sil | 5 ± 2 | 7 ± 3 | 30 ± 6* | 70 ± 9* | 64 ± 8* |
kt+sil | 4 ± 2 | 6 ± 3 | 31 ± 8* | 64 ± 12* | 60 ± 9* |
kt | 4 ± 2 | 6 ± 3 | 31 ± 9* | 77 ± 10* | 70 ± 8* |
Coronary flow (ml * min -1 /g dry heart weight) | |||||
con | 101 ± 15 | 100 ± 14 | 59 ± 5* | 56 ± 3* | |
sil | 95 ± 22 | 100 ± 21 | 66 ± 15* | 59 ± 13* | |
kt+sil | 100 ± 21 | 100 ± 21 | 61 ± 11* | 57 ± 14* | |
kt | 92 ± 20 | 89 ± 23 | 62 ± 6* | 59 ± 7* |
Data are mean±SD. con = control; sil = sildenafil; kt = kt5823. RPP = rate pressure product; LVEDP = left ventricular end-diastolic pressure.
*P<0.05 versus baseline.